Influence of ovarian hormones on skeletal muscle contractility

Research output: Chapter in Book/Report/Conference proceedingChapter


There is a loss of skeletal muscle strength around the time of menopause in women, probably due to the decline of ovarian hormone production. The maintenance of muscle strength and contractility with age and with loss of ovarian hormones are critical issues because the risk for disability and dependent living increases with muscle weakness. There is substantial evidence that estradiol is beneficial to muscle strength. Thus, better understanding of the mechanisms by which estradiol affects contractility and how the loss of this hormone is detrimental to skeletal muscle function is critical. This chapter focuses on ovarian hormones, specifically how the lack of estradiol affects skeletal muscle contractility in both postmenopausal women and rodent models.

Original languageEnglish (US)
Title of host publicationIntegrative Biology of Women's Health
PublisherSpringer New York
Number of pages15
ISBN (Electronic)9781461486305
ISBN (Print)1461486297, 9781461486299
StatePublished - Dec 1 2013

Bibliographical note

Publisher Copyright:
© 2013 Springer Science+Business Media New York.


  • Aging
  • Estradiol
  • Estrogen
  • Hormone replacement therapy
  • Muscle force
  • Myosin
  • Ovariectomy
  • Postmenopausal
  • Power
  • Strength


Dive into the research topics of 'Influence of ovarian hormones on skeletal muscle contractility'. Together they form a unique fingerprint.

Cite this